ANI Pharmaceuticals (ANIP) OCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | 3.32 | -31.2 | 119.0 | 64.0 | 185.2 | 208.6 | ||
| Changes by years, y/y, % | -78% | -1 039% | -481% | -46% | +189% | +64.7% | |||
ANI Pharmaceuticals. OCF, bln rub
ANI Pharmaceuticals. OCF, changes, %
ANI Pharmaceuticals. OCF, sum by quarters, bln rub
ANI Pharmaceuticals (ANIP) OCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| OCF, bln rub | ? | 35.0 | 75.8 | 44.1 | 30.4 | 58.4 | 208.6 | |
| Changes by years, y/y, % | +92% | +335% | +253% | +91% | +67% | |||
| Changes by quarters, q/q, % | +121% | +117% | -42% | -31% | +92% | |||